Pyxis Oncology

Forecast & Rating10 analysts currently cover Pyxis Oncology, with about 90.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $8.67, about 310.7% upside from the current price of $2.11. Price targets range from $6.00 to $19.00 — a wide spread, showing clear disagreement over just how much Pyxis Oncology can rise. Historically, about 5.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Pyxis Oncology closely still see room for the stock to rise. Data as of Sep 22, 2026; for reference only and not investment advice.